MNPR 8-K 2026-06-23

Monopar Therapeutics (MNPR) 8-K dated 2026-06-23 — accession 0001437749-26-021350. This URL is the filing, not the MNPR hub.

Monopar Therapeutics (MNPR) is a biotechnology company listed on US.

Monopar Therapeutics filed a 8-K on 2026-06-23. Accession 0001437749-26-021350.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.

Not investment advice. The MNPR SEC hub lists recent forms. The stock page is the research view.